Company: Amgen
Tags: general, territory
Two years post-acquisition and the Horizon integration is still rough in the field. Before the deal, Tepezza reps had deep relationships with endocrinologists and ophthalmologists who were invested in thyroid eye disease. Amgen came in and reorganized the field structure twice, shuffled territories, and in my region we're now on our third DM in 18 months. Physician confidence in continuity has taken a real hit. I've had accounts that were reliably converting tell me they're going back to watchful waiting because they don't want to deal with the insurance prior auth complexity without the rep s
43 upvotes · 5 comments